Stonepine Capital Management, LLC Xeris Biopharma Holdings, Inc. Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$2.04 - $3.22 $10.9 Million - $17.2 Million
-5,338,914 Reduced 89.93%
598,086 $1.32 Billion
Q4 2023

Feb 13, 2024
BUY
$1.47 - $2.36 $31,793 - $51,042
21,628 Added 0.37%
5,937,000 $14 Billion
Q3 2023

Nov 13, 2023
BUY
$1.8 - $2.69 $10.6 Million - $15.9 Million
5,915,372 New
5,915,372 $11 Billion
Q2 2023

Aug 11, 2023
SELL
$1.82 - $2.98 $5.71 Million - $9.36 Million
-3,139,977 Reduced 36.34%
5,500,228 $14.4 Million
Q1 2023

May 12, 2023
SELL
$1.03 - $1.63 $2.63 Million - $4.16 Million
-2,554,984 Reduced 22.82%
8,640,205 $14.1 Million
Q4 2022

Feb 14, 2023
SELL
$1.14 - $1.65 $1.98 Million - $2.86 Million
-1,732,979 Reduced 13.4%
11,195,189 $14.9 Million
Q3 2022

Nov 10, 2022
BUY
$1.37 - $1.93 $1.75 Million - $2.47 Million
1,280,751 Added 11.0%
12,928,168 $20.2 Million
Q2 2022

Aug 12, 2022
BUY
$1.48 - $2.64 $5.51 Million - $9.83 Million
3,723,361 Added 46.99%
11,647,417 $17.9 Million
Q1 2022

May 16, 2022
BUY
$2.0 - $2.87 $4.54 Million - $6.51 Million
2,267,683 Added 40.09%
7,924,056 $20.3 Million
Q4 2021

Feb 14, 2022
BUY
$1.8 - $2.93 $10.2 Million - $16.6 Million
5,656,373 New
5,656,373 $16.6 Million

Others Institutions Holding XERS

# of Institutions
143
Shares Held
60M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email